ICH E11(R1) step 5 guideline on clinical investigation of medicinal products in the pediatric population

Current effective version

PDF iconRevision 1 - Adopted addendum

Revision 1 enters into effect - see below

Reference numberEMA/CPMP/ICH/2711/1999
Effective from28/02/2017
KeywordsPaediatric medicinal product development, age categories, ethics, paediatric formulation, pharmacokinetic
DescriptionThis document provides an outline of critical issues in pediatric drug development and approaches to the safe, efficient, and ethical study of medicinal products in the pediatric population. The purpose of this addendum is to complement and provide clarification and current regulatory perspective on topics in pediatric drug development.

Document history

Revision 1

PDF iconAdopted addendum

PDF iconOverview of comments

PDF iconDraft addendum

Published: 06/10/2017
Effective from: 28/02/2018

Updated: 28/04/2017

Published: 13/10/2016

First version

Current version

Adopted guideline

In operation: 21/01/2001-present

How useful was this page?

Add your rating